Gene · 7791
ZYX: zyxin
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ZYX: zyxin. Genes, record 7791. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/7791
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q15942 | Zyxin | 572 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents62
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 71001 | Q15942 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 5551 | Q15942 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 788 | Q15942 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 5173 | Q15942 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 788 | Q15942 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 5173 | Q15942 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 5551 | Q15942 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 38637 | Q15942 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 38637 | Q15942 | Espacenet |
| EP 4373841 A1 | 2024-05-29 | 59 | Q15942 | Espacenet |
1 to 10 of 62
See all 62 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,264
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ZYX papers | Newest fiscal year |
|---|---|---|---|
| P30CA042014 | Cancer Center Support Grant | 15 | 2025 |
| ZIAHL005105 | Integration of Actin Dynamics and Adhesion in Cell Migration | 9 | 2025 |
| R01EY013322 | Assessment of Corneal Fibroblast Biomechanical Behavior | 8 | 2025 |
| ZIAHL005104 | Cell Migration in 3D microenvironments | 7 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| P30CA036727 | Buffett Cancer Center Support Grant | 5 | 2025 |
| P30DK084567 | Mayo Center for Cell Signaling in Gastroenterology | 4 | 2025 |
| R35GM118096 | Regulating cell fate and shaping the body plan during morphogenesis and their alteration during oncogenesis | 4 | 2025 |
| ZIADE000524 | Cell-Matrix Interactions and Migration | 4 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 3 | 2025 |
1 to 10 of 1,264Source NIH's project files
See all 1,264 nih grantsPapers1,771
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Decline zyxin and CALLY index as predictors of cardiovascular diseases in patients with T2DM. | Wiad Lek | 2026 | 42359857 | PubTator, text mining | PubMed |
| Sweetening the bonds: how O-GlcNAcylation modulates cell adhesion. | Acta Pharmacol Sin | 2026 | 42332029 | PubTator, text mining | PubMed |
| Magnetic torque-mediated early asymmetric mechanical stimulation directs structural and functional maturation in human cardiac organoids. | Sci Rep | 2026 | 42115257 | PubTator, text mining | PubMed |
| Reconstituted nascent adhesion condensates drive actin polymerization on supported lipid bilayers. | Sci Adv | 2026 | 42102206 | PubTator, text mining | PubMed |
| Myosin forces remodel F-actin for mechanosensitive protein recognition. | Nature | 2026 | 42020745 | PubTator, text mining | PubMed |
| Distinct Proteomic Signatures Driving Progression of Sarcopenia: A Longitudinal Multicohort Study. | J Cachexia Sarcopenia Muscle | 2026 | 41782349 | PubTator, text mining | PubMed |
| Lactylation-based machine algorithm combined with multi-omics analysis to predict prognosis in cervical cancer. | Oncol Lett | 2026 | 41743011 | PubTator, text mining | PubMed |
| The Potential Link and Role of Zyxin in the Pathogenesis of Psoriasis and Its Associated Comorbidities. | Int J Mol Sci | 2026 | 41596291 | PubTator, text mining | PubMed |
| Persistent immune, coagulation and cardiac dysregulation are correlated with later post-discharge mortality in children with severe malnutrition. | BMC Med | 2026 | 41572258 | PubTator, text mining | PubMed |
| Focal Adhesion and Cancer Cell Cycle-Associated Resistance. | ACS Omega | 2026 | 41552449 | PubTator, text mining | PubMed |
1 to 10 of 1,771
See all 1,771 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/7791
GET https://conductscience.org/api/genes/v1/7791/patents?page=2